Article History
Received: 30 December 2023
Accepted: 12 March 2024
First Online: 2 May 2024
Declarations
:
: No funding was received to assist with the preparation of this manuscript. Claire Hill has served in an advisory capacity for Mereo BioPharma and Ultragenyx. Concept and literature search was performed by Claire Hill. All authors contributed to the manuscript, revised the paper critically for intellectual content and have approved the final draft. All authors agree to be accountable for the work and to ensure that any questions relating to the accuracy and integrity of the paper are investigated and properly resolved.